ArticleJournal of frailty, sarcopenia and falls2025
The Impact of Sarcopenic Obesity on Frailty, Cognition, and Function in Community-Dwelling Older Adults.
Article in Journal of frailty, sarcopenia and falls, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Relationship Between Cognitive Performance and Anthropometric Status, Dietary Diversity, and Diet Quality in Older Turkish Adults: A Cross-Sectional Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The impact of sarcopenic obesity (SO) on frailty, cognition, and function compared to sarcopenia and obesity alone remains unclear. This study examined SO's effects on these domains in community-dwelling older adults. Methods: We assessed 202 older adults (mean age 80.4 ±7.3 years) attending a community frailty screening clinic. Obesity was defined as BMI≥25, and sarcopenia was assessed using Asian Working Group for Sarcopenia guidelines. SO was defined as the presence of both conditions. Assessments included the Clinical Frailty Scale, Modified Barthel Index, Singapore-modified Mini-Mental State Examination, and mobility aid use. Results: Multivariate regression showed SO was significantly associated with frailty (OR 4.71), impaired function (ß: -16.53), and mobility limitations (OR 5.73). SO was also linked to cognitive impairment (OR 3.56). Sarcopenia alone was associated with frailty (OR 3.39), impaired function (ß -11.46), and mobility limitations (OR 3.32), but not cognition. Obesity alone showed no associations. SO posed higher risks for frailty, cognitive impairment, functional decline, and mobility limitations compared to sarcopenia or obesity alone. Conclusions: SO is associated with greater risks of frailty, cognitive impairment, functional decline, and mobility limitations than sarcopenia or obesity alone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.